Gender impacts on the correlations between nonalcoholic fatty liver disease and hypertension in a Chinese population aged 45–60 y

Reference

• Noohi F, Sarrafzadegan N, Khosravi A, Andalib E. The first Iranian recommendations on prevention, evaluation and management of high blood pressure. ARYA Atheroscler 2012;8:97–118.
   PubMedGoogle Scholar
• Li YC, Wang LM, Jiang Y, et al. Prevalence of hypertension among Chinese adults in 2010. Zhonghua Yu Fang Yi Xue Za Zhi 2012;46:409–413.
   PubMedGoogle Scholar
• Zhai F, Wang H, Du S, et al. Prospective study on nutrition transition in China. Nutr Rev 2009;67(Suppl 1):56–61.
   Web of Science ®Google Scholar
• Fields LE, Burt VL, Cutler JA, et al. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension 2004;44:398–404.
   PubMed Web of Science ®Google Scholar
• Luo L, Luan RS, Yuan P. Meta-analysis of risk factors on hypertension in China. Zhanghua Liu Xing Bing Xue Za Zhi 2003;2420:50–53.
   Google Scholar
• Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011;34:274–85.
   PubMed Web of Science ®Google Scholar
• Hou XH, Zhu YX, Lu HJ, et al. Non-alcoholic fatty liver disease’s prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the Chinese. J Gastroenterol Hepatol 2011;26:722–730.
   PubMed Web of Science ®Google Scholar
• Hamaguchi M, Kojima T, Takeda N, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005;143:722–28.
   PubMed Web of Science ®Google Scholar
• Zelber-Sagi S, Lotan R, Shlomai A, et al. Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up. J Hepatol 2012;56:1145–51.
   PubMed Web of Science ®Google Scholar
• Zelber-Sagi S, Nitzan-Kaluski D, Halpern Z, et al. Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures. Liver Int 2006;26:856–63.
   PubMed Web of Science ®Google Scholar
• Marchesini G, Marzocchi R, Agostini F, Bugianesi E. Nonalcoholic fatty liver disease and the metabolic syndrome. Curr Opin Lipidol 2005;16:421–7.
   PubMed Web of Science ®Google Scholar
• Sainsbury CA, Sattar N, Connell JM, et al. Non-esterified fatty acids impair endothelium-dependent vasodilation in rat mesenteric resistance vessels. Clin Sci (Lond) 2004;107(6):625–9.
   PubMed Web of Science ®Google Scholar
• Ryoo JH, Ham WT, Choi JM, et al. Clinical significance of non-alcoholic fatty liver disease as a risk factor for prehypertension. J Korean Med Sci 2014;29(7):973–9.
   PubMed Web of Science ®Google Scholar
• Esmaillzadeh A, Kimiaqar M, Mehrabi Y, et al. Dietary patterns, insulin resistance, and prevalence of the metabolic syndrome in women. Am J Clin Nutr 2007;85:910–8.
   PubMed Web of Science ®Google Scholar
• Berg CM, Lappas G, Strandhagen E, et al. Food patterns and cardiovascular disease risk factors: the Swedish INTERGENE research program. Am J Clin Nutr 2008;88:289–97.
   PubMed Web of Science ®Google Scholar
• Zuo H, Shi Z, Yuan B, et al. Interaction between physical activity and sleep duration in relation to insulin resistance among non-diabetic Chinese adults. BMC Public Health 2012;12:247.
   PubMed Web of Science ®Google Scholar
• Sanyal AJ. American Gastroenterological Association. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002;123(5):1705–25.
   PubMedGoogle Scholar
• Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003;289:2560–72.
   Google Scholar
• Sung KC, Ryan MC, Wilson AM. The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects. Atherosclerosis 2009;203:581–6.
   PubMed Web of Science ®Google Scholar
• Choi SY, Kim D, Kim HJ, et al. The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans. Am J Gastroeneterol 2009;104:1953–60.
   PubMed Web of Science ®Google Scholar
• Kern PA, Di Gregorio GB, Lu T, et al. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 2003;52:1779–85.
   PubMed Web of Science ®Google Scholar
• Kern PA, Ranganathan S, Li C, et al. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001;280:E745–51.
   PubMed Web of Science ®Google Scholar
• Targher G, Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis 2007;191:235–40.
   PubMed Web of Science ®Google Scholar
• Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001;50:1844–50.
   PubMed Web of Science ®Google Scholar
• Yesilova Z, Yaman H, Oktenli C, et al. Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic Fatty liver disease. Am J Gastroenterol 2005;100:850–5.
   PubMed Web of Science ®Google Scholar
• Matsuzawa Y, Funahashi T, Kihara S, et al. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004;24:29–33.
   PubMed Web of Science ®Google Scholar
• Pischon T, Girman CJ, Hotamisligil GS, et al. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004;29:1730–7.
   Web of Science ®Google Scholar
• Xun P, Wu Y, He Q, He K. Fasting insulin concentrations and incidence of hypertension, stroke, and coronary heart disease: a meta-analysis of prospective cohort studies. Am J Clin Nutr 2013;98(6):1543–54.
   PubMed Web of Science ®Google Scholar
• Zhang T, Zhang H, Li S, et al. Impact of adiposity on incident hypertension is modified by insulin resistance in adults: longitudinal observation from the bogalusa heart study. Hypertension 2016;67(1):56–62.
   PubMed Web of Science ®Google Scholar
• Grassi G, Mark A, Esler M. The sympathetic nervous system alterations in human hypertension. Circ Res 2015;116(6):976–90.
   PubMed Web of Science ®Google Scholar
• Ryoo JH, Suh YJ, Shin HC, et al. Clinical association between non-alcoholic fatty liver disease and the development of hypertension. J Gastroenterol Hepatol 2014;29(11):1926–31.
   PubMed Web of Science ®Google Scholar
• Lim TS, Hong JM, Lee JS, et al. Induced-hypertension in progressing lacunar infarction. J Neurol Sci 2011;308:72–6.
   PubMed Web of Science ®Google Scholar
• Yahyaoui R, Esteva I, Haro-Mora JJ, et al. Effect of long-term administration of cross-sex hormone therapy on serum and urinary uric acid in transsexual persons. J Clin Endocrinol Metab 2008;93:2230–2233.
   PubMed Web of Science ®Google Scholar
• Wang SF, Shu L,Wang S, et al. Gender difference in the association of hyperuricemia with hypertension in a middle-aged Chinese population. Blood Press 2014;23(6):339–44.
   PubMed Web of Science ®Google Scholar
• Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003;98:960–967.
   PubMed Web of Science ®Google Scholar
• Rasiah R, Thangiah G, Yusoff K, et al. The impact of physical activity on cumulative cardiovascular disease risk factors among Malaysian adults. BMC Public Health 2015;15:1242.
   PubMed Web of Science ®Google Scholar
• Lee SA, Xu WH, Zheng W, et al. Physical activity patterns and their correlates among Chinese men in Shanghai. Med Sci Sports Exerc 2007;39:1700–1707.
   PubMed Web of Science ®Google Scholar